Global Patent Index - EP 1161451 A2

EP 1161451 A2 2001-12-12 - HUMAN ENDOKINE ALPHA AND METHODS OF USE

Title (en)

HUMAN ENDOKINE ALPHA AND METHODS OF USE

Title (de)

MENSCHLICHES ALPHA-ENDOKIN UND VERFAHREN ZU SEINER VERWENDUNG

Title (fr)

ENDOKINE ALPHA HUMAIN ET METHODES D'UTILISATION

Publication

EP 1161451 A2 (EN)

Application

EP 00913602 A

Priority

  • US 0004722 W
  • US 12209999 P
  • US 13678899 P

Abstract (en)

[origin: WO0050620A2] The present invention concerns a novel member of the tumor necrosis factor (TNF) family of cytokines. In particular, isolated nucleic acid molecules are provided encoding the endokine alpha protein. Endokine alpha polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. Also provided are diagnostic and therapeutic methods concerning TNF family-related disorders.

IPC 1-7 (main, further and additional classification)

C07K 14/52; A61K 38/16; A61K 38/19; C12N 5/10; C12N 5/16; C12N 15/19; C12N 15/63

IPC 8 full level (invention and additional information)

C07K 14/525 (2006.01); A61K 38/00 (2006.01)

CPC (invention and additional information)

C07K 14/5255 (2013.01); A61K 38/00 (2013.01)

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 0050620 A2 20000831; WO 0050620 A3 20001130; AU 3501700 A 20000914; CA 2363779 A1 20000831; EP 1161451 A2 20011212; EP 1161451 A4 20060517; EP 2357192 A1 20110817; JP 2002537769 A 20021112; JP 2010252803 A 20101111

INPADOC legal status


2010-11-03 [18W] APPLICATION WITHDRAWN

- Effective date: 20100927

2008-08-13 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20080715

2006-05-17 [A4] DESPATCH OF SUPPLEMENTARY SEARCH REPORT

- Effective date: 20060330

2001-12-12 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20010926

2001-12-12 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A2

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

2001-12-12 [AX] REQUEST FOR EXTENSION OF THE EUROPEAN PATENT TO:

- Free text: AL;LT;LV;MK;RO;SI